Glia and Epilepsy: Excitability
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Dynamic Regulation of Synaptic GABA Release by the Glutamate-Glutamine Cycle in Hippocampal Area CA1
The Journal of Neuroscience, August 16, 2006 • 26(33):8537–8548 • 8537 Development/Plasticity/Repair Dynamic Regulation of Synaptic GABA Release by the Glutamate-Glutamine Cycle in Hippocampal Area CA1 Shu-Ling Liang,1 Gregory C. Carlson,1 and Douglas A. Coulter1,2 1Division of Neurology and the Pediatric Regional Epilepsy Program, Children’s Hospital of Philadelphia, and 2Departments of Pediatrics, Neurology, and Neuroscience, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 Vesicular GABA and intraterminal glutamate concentrations are in equilibrium, suggesting inhibitory efficacy may depend on glutamate availability. Two main intraterminal glutamate sources are uptake by neuronal glutamate transporters and glutamine synthesized through the astrocytic glutamate-glutamine cycle. We examined the involvement of the glutamate-glutamine cycle in modulating GABAergic synaptic efficacy. In the absence of neuronal activity, disruption of the glutamate-glutamine cycle by blockade of neuronal glutamine transport with ␣-(methylamino) isobutyric acid (MeAIB; 5 mM) or inhibition of glutamine synthesis in astrocytes with methionine sulfoximine (MSO; 1.5 mM) had no effect on miniature IPSCs recorded in hippocampal area CA1 pyramidal neurons. How- ever, after a period of moderate synaptic activity, application of MeAIB, MSO, or dihydrokainate (250 M; an astrocytic glutamate transporter inhibitor) significantly reduced evoked IPSC (eIPSC) amplitudes. The MSO effect could be reversed by exogenous application of glutamine (5 mM), whereas glutamine could not rescue the eIPSC decreases induced by the neuronal glutamine transporter inhibitor MeAIB. The activity-dependent reduction in eIPSCs by glutamate-glutamine cycle blockers was accompanied by an enhanced blocking effect of the low-affinity GABAA receptor antagonist, TPMPA [1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid], consistent with diminished GABA release. -
Methionine Sulfoximine: a Novel Anti Inflammatory Agent
Wayne State University Wayne State University Dissertations January 2018 Methionine Sulfoximine: A Novel Anti Inflammatory Agent Tyler Peters Wayne State University, [email protected] Follow this and additional works at: https://digitalcommons.wayne.edu/oa_dissertations Part of the Biochemistry Commons Recommended Citation Peters, Tyler, "Methionine Sulfoximine: A Novel Anti Inflammatory Agent" (2018). Wayne State University Dissertations. 2124. https://digitalcommons.wayne.edu/oa_dissertations/2124 This Open Access Dissertation is brought to you for free and open access by DigitalCommons@WayneState. It has been accepted for inclusion in Wayne State University Dissertations by an authorized administrator of DigitalCommons@WayneState. METHIONINE SULFOXIMINE: A NOVEL ANTI-INFLAMMATORY AGENT by TYLER J. PETERS DISSERTATION Submitted to the Graduate School of Wayne State University – School of Medicine Detroit, Michigan in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOHPY 2018 MAJOR: BIOCHEMISTRY & MOL. BIOLOGY Approved By: __________________________________________ Advisor Date DEDICATION This work is dedicated to my family. I wouldn’t have made it this far without your unconditional love and support. ii ACKNOWLEDGEMENTS Thank you Dr. Brusilow, I consider myself very fortunate for having the privilege of working in the laboratory of Dr. William S.A. Brusilow these past few years. Under his mentorship, my scientific autonomy was always respected, and my opinions were always valued with consideration. I am thankful for his guidance and support as an advisor; I truly admire his patience and envy his calm demeanor. He exemplifies scientific integrity, and his dedication to develop MSO has inspired me. I had never experienced consistent failure in any aspect of life before encountering scientific research; at times I felt that Dr. -
Glutamate and GABA Dynamics in Early Ischaemia of Rat
J. Physiol. (2002). 543.P Research Symposium – Mechanisms of Ischaemic Cell Death 25S ATP occurring in ischaemia may prevent a protective uptake of glutamate into glia in early ischaemia: with glutamine synthetase Glutamate and GABA dynamics in early ischaemia of rat inhibited, uptake of only a little glutamate released from neurons hippocampal slices may be sufficient to raise [glutamate]i in glia sufficiently to D. Attwell, N.J. Allen, M. Hamman and D.J. Rossi inhibit further uptake. Department of Physiology, University College London, Gower Street, Hamann, M. et al. (2002). Eur. J. Neurosci. 15, 308–314. London WC1E 6BT, UK Rossi, D.J. et al. (2000). Nature 403, 316–321. During brain ischaemia, the run-down of transmembrane ion gradients caused by the fall of ATP levels occurring leads to a rise This work was supported by The Wellcome Trust. in extracellular glutamate and GABA concentrations. The rise of glutamate concentration triggers neuronal death. In simulated All procedures accord with current local guidelines. ischaemia of hippocampal slices, taken from rats humanely killed in accordance with UK animal use legislation, we have used receptors in whole-cell patch-clamped CA1 pyramidal cells to sense released glutamate and GABA. ECl was set to 0 mV, so that currents mediated by ionotropic GABA receptors were inward, Cation channels: a radical way of killing cells and membrane current was recorded at _30 mV to allow glutamate sensing by NMDA and AMPA receptors. Mike Ashford On applying superfusion solution mimicking the energy University of Dundee deprivation occurring during severe ischaemia (no oxygen and glucose, cyanide and iodoacetate present), a slow small increase of inward current occurred over the first few minutes, followed by a sudden massive inward current (nanoamps) which then sagged back to a less inward plateau (Rossi et al. -
Aldrich Raman
Aldrich Raman Library Listing – 14,033 spectra This library represents the most comprehensive collection of FT-Raman spectral references available. It contains many common chemicals found in the Aldrich Handbook of Fine Chemicals. To create the Aldrich Raman Condensed Phase Library, 14,033 compounds found in the Aldrich Collection of FT-IR Spectra Edition II Library were excited with an Nd:YVO4 laser (1064 nm) using laser powers between 400 - 600 mW, measured at the sample. A Thermo FT-Raman spectrometer (with a Ge detector) was used to collect the Raman spectra. The spectra were saved in Raman Shift format. Aldrich Raman Index Compound Name Index Compound Name 4803 ((1R)-(ENDO,ANTI))-(+)-3- 4246 (+)-3-ISOPROPYL-7A- BROMOCAMPHOR-8- SULFONIC METHYLTETRAHYDRO- ACID, AMMONIUM SALT PYRROLO(2,1-B)OXAZOL-5(6H)- 2207 ((1R)-ENDO)-(+)-3- ONE, BROMOCAMPHOR, 98% 12568 (+)-4-CHOLESTEN-3-ONE, 98% 4804 ((1S)-(ENDO,ANTI))-(-)-3- 3774 (+)-5,6-O-CYCLOHEXYLIDENE-L- BROMOCAMPHOR-8- SULFONIC ASCORBIC ACID, 98% ACID, AMMONIUM SALT 11632 (+)-5-BROMO-2'-DEOXYURIDINE, 2208 ((1S)-ENDO)-(-)-3- 97% BROMOCAMPHOR, 98% 11634 (+)-5-FLUORODEOXYURIDINE, 769 ((1S)-ENDO)-(-)-BORNEOL, 99% 98+% 13454 ((2S,3S)-(+)- 11633 (+)-5-IODO-2'-DEOXYURIDINE, 98% BIS(DIPHENYLPHOSPHINO)- 4228 (+)-6-AMINOPENICILLANIC ACID, BUTANE)(N3-ALLYL)PD(II) CL04, 96% 97 8167 (+)-6-METHOXY-ALPHA-METHYL- 10297 ((3- 2- NAPHTHALENEACETIC ACID, DIMETHYLAMINO)PROPYL)TRIPH 98% ENYL- PHOSPHONIUM BROMIDE, 12586 (+)-ANDROSTA-1,4-DIENE-3,17- 99% DIONE, 98% 13458 ((R)-(+)-2,2'- 963 (+)-ARABINOGALACTAN BIS(DIPHENYLPHOSPHINO)-1,1'- -
Altered Protein Profiles During Epileptogenesis in the Pilocarpine
ORIGINAL RESEARCH published: 28 May 2021 doi: 10.3389/fneur.2021.654606 Altered Protein Profiles During Epileptogenesis in the Pilocarpine Mouse Model of Temporal Lobe Epilepsy Md. Mahiuddin Ahmed 1, Andrew J. Carrel 2, Yasmin Cruz Del Angel 2, Jessica Carlsen 2, Ajay X. Thomas 2,3,4, Marco I. González 2, Katheleen J. Gardiner 5† and Amy Brooks-Kayal 2,6,7,8*† 1 Department of Neurology, University of Colorado Alzheimer’s and Cognition Center, Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, CO, United States, 2 Division of Neurology and Translational Epilepsy Research Program, Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, United States, 3 Section of Neurology and Developmental Neuroscience, Department of Pediatrics, Baylor College of Medicine, Houston, TX, United States, 4 Section of Child Neurology, Texas Children’s Hospital, Houston, TX, United States, Edited by: 5 Department of Pediatrics, Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Kjell Heuser, Aurora, CO, United States, 6 Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Oslo University Hospital, Norway Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, United States, 7 Children’s Hospital Colorado, Reviewed by: Aurora, CO, United States, 8 Department of Neurology, University of California Davis School of Medicine, Sacramento, CA, Victor Rodrigues Santos, United States Federal University of Minas Gerais, Brazil Divya Vohora, Epilepsy is characterized by recurrent, spontaneous seizures and is a major contributor Jamia Hamdard University, India to the global burden of neurological disease. Although epilepsy can result from a variety *Correspondence: of brain insults, in many cases the cause is unknown and, in a significant proportion Amy Brooks-Kayal of cases, seizures cannot be controlled by available treatments. -
Analytical Method Developments of Antibody Drug Conjugates And
Analytical method developments of antibody drug conjugates and disease biomarkers in microdialysis samples By Yunan Wang Submitted to the graduate degree program in Chemistry and the Graduate Faculty of the University of Kansas in partial fulfillment of the requirements for the degree of Doctor of Philosophy. ________________________________ Chairperson Dr. Susan Lunte ________________________________ Dr. Heather Desaire ________________________________ Dr. Julie Stenken ________________________________ Dr. Robert Dunn ________________________________ Dr. Zhuo Wang Date Defended: January 27th, 2016 The Dissertation Committee for Yunan Wang certifies that this is the approved version of the following dissertation: Analytical method developments of antibody drug conjugates and disease biomarkers in microdialysis samples ________________________________ Chairperson Dr. Susan Lunte Date approved: February 1st, 2016 ii Abstract This dissertation focuses on developing analytical methods to study biomarkers in different pharmaceutical samples. Three different analytical methods were developed for microdialysis samples and antibody drug conjugates as anti-tumor drug. The first part of this dissertation is to develop a capillary electrophoresis with laser induced fluorescence (CE-LIF) method to monitor the change of amino acids in rat brain microdialysate as biomarkers of oxidative stress in epileptic seizures. Ornithine and citrulline was successfully separated and quantified. 3-Mercaptopropionic acid (3- MPA) was administrated to rat brain hippocampus region as a convulsant to induce epileptic seizures to free-moving rats. An increase of citrulline and ornithine level was observed after the seizure, and this confirmed nitric oxide were produced in epileptic seizures. In the second project, a high-performance liquid chromatography with mass spectrometry (HPLC-MS) method is developed to simultaneously monitor the change of 13 eicosanoids as biomarkers in rat colon microdialysate to study the enzymatic pathways of inflammatory bowel disease. -
Subsets Underlies IL-6 Signaling in Glial Β Differential
Differential TGF-β Signaling in Glial Subsets Underlies IL-6−Mediated Epileptogenesis in Mice This information is current as Nitzan Levy, Dan Z. Milikovsky, Gytis Baranauskas, of October 1, 2021. Ekaterina Vinogradov, Yaron David, Maya Ketzef, Shai Abutbul, Itai Weissberg, Lyn Kamintsky, Ilya Fleidervish, Alon Friedman and Alon Monsonego J Immunol 2015; 195:1713-1722; Prepublished online 1 July 2015; doi: 10.4049/jimmunol.1401446 Downloaded from http://www.jimmunol.org/content/195/4/1713 References This article cites 50 articles, 13 of which you can access for free at: http://www.jimmunol.org/ http://www.jimmunol.org/content/195/4/1713.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on October 1, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2015 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Differential TGF-b Signaling in Glial Subsets Underlies IL-6–Mediated Epileptogenesis in Mice Nitzan Levy,*,†,1 Dan Z. -
Post Traumatic Epilepsy : a Review of Scientific Evidence
Indian J Physiol Pharmacol 2006; 50 (1) : 7–16 REVIEW ARTICLE POST TRAUMATIC EPILEPSY : A REVIEW OF SCIENTIFIC EVIDENCE Y. K. GUPTA* AND MADHUR GUPTA Neuropharmacology Laboratory, Department of Pharmacology, All India Institute of Medical Sciences, New Delhi – 110 029 ( Received on July 15, 2005 ) Abstract : Post traumatic epilepsy is the development of recurrent seizures following head trauma and has a high clinical relevance. Several risk factors including some genetic factors increase the susceptibility of post traumatic epilepsy. The precise mechanisms of epileptogenesis in post-traumatic epilepsy are still poorly understood. Many structural, physiologic and biochemical changes in the brain may account for . epileptogenesis. The reactive oxygen species (ROS), especially OH and excitotoxicity are primarily involved. Antioxidants, like tocopherol, antiepileptic drug zonisamide, condensed tannins, melatonin, adenosine, trans-resveratrol, and some other agents have been proposed to prevent epileptogenic focus formation. The review also discusses various aspects of post traumatic epilepsy, mechanisms of epileptogenesis, and clinical implications. Key words : epilepsy trauma posttraumatic seizure oxidative stress INTRODUCTION recurrent epileptic seizures due to brain damage (2). It complicates the management Epilepsy is one of the most common of the head injuries patients by increasing neurological disorders affecting nearly 0.5 the intracranial pressure and altering percent of the world population (1). the level of unconsciousness. Among the Traumatic brain injury, which is a major long term complications of traumatic cause of morbidity and mortality world wide, brain injury, post traumatic epilepsy has been reported to be one of the major remains one of the most troubling and in risk factor for epileptic seizures. -
Reactive Astrocyte-Driven Epileptogenesis Is Induced by Microglia Initially Activated Following Status Epilepticus
Reactive astrocyte-driven epileptogenesis is induced by microglia initially activated following status epilepticus Fumikazu Sano, … , Masao Aihara, Schuichi Koizumi JCI Insight. 2021;6(9):e135391. https://doi.org/10.1172/jci.insight.135391. Research Article Neuroscience Graphical abstract Find the latest version: https://jci.me/135391/pdf RESEARCH ARTICLE Reactive astrocyte-driven epileptogenesis is induced by microglia initially activated following status epilepticus Fumikazu Sano,1,2,3 Eiji Shigetomi,1,3 Youichi Shinozaki,1,3 Haruka Tsuzukiyama,1 Kozo Saito,1,3,4 Katsuhiko Mikoshiba,5 Hiroshi Horiuchi,6 Dennis Lawrence Cheung,6 Junichi Nabekura,6 Kanji Sugita,2 Masao Aihara,2 and Schuichi Koizumi1,3 1Department of Neuropharmacology, Interdisciplinary Graduate School of Medicine, 2Department of Pediatrics, Faculty of Medicine, and 3Yamanashi GLIA Center, Interdisciplinary Graduate School of Medicine, University of Yamanashi, Yamanashi, Japan. 4Department of Neurology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan. 5Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai, China. 6Division of Homeostatic Development, National Institute for Physiological Sciences, Okazaki, Japan. Extensive activation of glial cells during a latent period has been well documented in various animal models of epilepsy. However, it remains unclear whether activated glial cells contribute to epileptogenesis, i.e., the chronically persistent process leading to epilepsy. Particularly, it is not clear whether interglial communication between different types of glial cells contributes to epileptogenesis, because past literature has mainly focused on one type of glial cell. Here, we show that temporally distinct activation profiles of microglia and astrocytes collaboratively contributed to epileptogenesis in a drug-induced status epilepticus model. -
Pharmacological Studies on a Locust Neuromuscular Preparation
J. Exp. Biol. (1974). 6i, 421-442 421 *&ith 2 figures in Great Britain PHARMACOLOGICAL STUDIES ON A LOCUST NEUROMUSCULAR PREPARATION BY A. N. CLEMENTS AND T. E. MAY Woodstock Research Centre, Shell Research Limited, Sittingbourne, Kent {Received 13 March 1974) SUMMARY 1. The structure-activity relationships of agonists of the locust excitatory neuromuscular synapse have been reinvestigated, paying particular attention to the purity of compounds, and to the characteristics and repeatability of the muscle response. The concentrations of compounds required to stimu- late contractions of the retractor unguis muscle equal in force to the neurally evoked contractions provided a measure of the relative potencies. 2. Seven amino acids were capable of stimulating twitch contractions, glutamic acid being the most active, the others being analogues or derivatives of glutamic or aspartic acid. Aspartic acid itself had no excitatory activity. 3. Excitatory activity requires possession of two acidic groups, separated by two or three carbon atoms, and an amino group a to a carboxyl. An L-configuration appears essential. The w-acidic group may be a carboxyl, sulphinyl or sulphonyl group. Substitution of any of the functional groups generally causes total loss of excitatory activity, but an exception is found in kainic acid in which the nitrogen atom forms part of a ring. 4. The investigation of a wide variety of compounds revealed neuro- muscular blocking activity among isoxazoles, hydroxylamines, indolealkyl- amines, /?-carbolines, phenazines and phenothiazines. No specific antagonist of the locust glutamate receptor was found, but synaptic blocking agents of moderately high activity are reported. INTRODUCTION The study of arthropod neuromuscular physiology has been impeded by the lack of an antagonist which can be used to block excitatory synaptic transmission by a specific postsynaptic effect. -
Epileptogenesis Causes Long-Term Plasticity Changes in Calbindin D-28K in the Rat Pilocarpine Model of Acquired Epilepsy
Virginia Commonwealth University VCU Scholars Compass Theses and Dissertations Graduate School 2005 Epileptogenesis Causes Long-Term Plasticity Changes in Calbindin D-28k in the Rat Pilocarpine Model of Acquired Epilepsy Anne Johnston Harrison Virginia Commonwealth University Follow this and additional works at: https://scholarscompass.vcu.edu/etd Part of the Neurology Commons © The Author Downloaded from https://scholarscompass.vcu.edu/etd/855 This Thesis is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact [email protected]. EPILEPTOGENESIS CAUSES LONG-TERM PLASTICITY CHANGES IN EXPRESSION OF CALBINDIN D-28K IN THE RAT PILOCARPINE MODEL OF ACQUIRED EPILEPSY A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science at Virginia Commonwealth University Anne Elizabeth Johnston Harrison Bachelor of Science in Pharmacy Virginia Commonwealth University May 1996 Bachelor of Science in Psychology The College of William and Mary May 1993 Director: Robert J. DeLorenzo, M.D., Ph.D., M.P.H. Professor Department of Neurology Virginia Convnonwealth University Richmond, Virginia December 2005 DEDICATION To my husband, Steve, for all of his encouragement, love, and support. Te amo mejo. ACKNOWLEDGEMENTS I would like to take this opportunity to thank a number of people without whom I could not have completed this thesis. Each of you has made immeasurable contributions to my education and personal growth. First, I must credit my family for their constant support, love, and encouragement in all of my endeavors, and for emphasizing the significance of continued learning throughout life. -
Clinical Approach to Posttraumatic Epilepsy
57 Clinical Approach to Posttraumatic Epilepsy Vikram R. Rao, MD, PhD1 Karen L. Parko, MD1,2 1 Department of Neurology, University of California, Address for correspondence Vikram R. Rao, MD, PhD, University of San Francisco, California California, San Francisco, Epilepsy Center, 400 Parnassus Ave, 8th 2 Department of Neurology, San Francisco Veterans Affairs Medical Floor, San Francisco, CA 94143 (e-mail: [email protected]). Center, San Francisco, California Semin Neurol 2015;35:57–63. Abstract Traumatic brain injury (TBI) is one of the most common causes of acquired epilepsy, and posttraumatic epilepsy (PTE) results in significant somatic and psychosocial morbidity. The risk of developing PTE relates directly to TBI severity, but the latency to first seizure can be decades after the inciting trauma. Given this “silent period,” much work has focused on identification of molecular and radiographic biomarkers for risk stratification and on development of therapies to prevent epileptogenesis. Clinical management requires vigilant neurologic surveillance and recognition of the heterogeneous endo- Keywords phenotypes associated with PTE. Appropriate treatment of patients who have or are at ► traumatic brain injury risk for seizures varies as a function of time after TBI, and the clinician’s armamentarium ► epilepsy includes an ever-expanding diversity of pharmacological and surgical options. Most ► posttraumatic recently, neuromodulation with implantable devices has emerged as a promising epilepsy therapeutic strategy for some patients with refractory PTE. Here, we review the ► seizure epidemiology, diagnostic considerations, and treatment options for PTE and develop ► neuromodulation a roadmap for providers encountering this challenging clinical entity. “…the brain may be injured by contusion, laceration, the wake of TBI.